BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 28, 2015
View Archived Issues
Shire reports pipeline progress of third quarter 2015
Read More
ClearPath Development launches NVC to develop vaccines against nosocomial bacterial infections
Read More
Hamni Science discloses cannabinoid CB1 receptor antagonists
Read More
SciVac Therapeutics plans to acquire VBI Vaccines
Read More
Roche and ETHZ report new cannabinoid CB2 receptor agonists
Read More
SiteOne and Stanford report sodium channel blockers for the treatment of pain
Read More
Small-molecule Dvl-CXXC5 antagonists show potential for the treatment of osteoporosis
Read More
ONO-8539: a new inhibitor of EP1 that reduces heartburn symptoms
Read More
Corvus Pharmaceuticals enters into trial collaboration with Genentech
Read More
4-Epi-isofagomine analogue shows promise for GM1-gangliosidosis and morquio syndrome type B
Read More
FDA approves Belbuca buccal film for chronic pain
Read More
Vertex and CRISPR Therapeutics establish research collaboration
Read More
MedImmune patents cytotoxic agents
Read More
Medshine Discovery patent details PARP-1 inhibitors
Read More
Shionogi divulges BACE1 inhibitors
Read More
Initial observations from phase II study of ganaxolone in PCDH19 female pediatric epilepsy
Read More
Therapeutic value of KML-29 in ALS and PD mice models
Read More
Hearing loss reduction with SENS-90 in severe noise model leads to clinical development
Read More
Japan's MHLW grants Sakigake designation to six drugs
Read More
Symic Biomedical advances SB-030 into clinical development
Read More
OPUS-3 trial of lifitegrast meets primary and key secondary endpoints for dry eye
Read More
Investigators report a novel mutation associated with Jalili syndrome
Read More
FDA approves Imlygic as first oncolytic viral therapy in U.S.
Read More
New derivative shows advantages over bumetanide as an anticonvulsant
Read More
Two phase III trials of Sativex in cancer pain report results
Read More
Allergan licenses rights to IBS-C therapy linaclotide from Almirall
Read More
Yakult Honsha licenses NIP-022 from Nissan Chemical
Read More
